BridgeBio Pharma, Inc. (BBIO)
NASDAQ · Healthcare
BridgeBio Pharma, Inc. Income Statement 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenue | 502.1M | 221.9M | 9.3M | 77.6M | 69.7M | 8.2M | 40.6M |
| Gross Profit | 481.1M | 218.0M | 6.9M | 74.2M | 66.6M | — | — |
| Profitability | |||||||
| Operating Income | -523.4M | -593.0M | -607.4M | -512.2M | -576.6M | -474.5M | -266.2M |
| EBITDA | -518.0M | -586.9M | -600.9M | -505.4M | -570.8M | -473.0M | -265.4M |
| Net Income | — | — | — | — | — | — | — |
| Per Share Data | |||||||
| EPS (diluted) | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 192M | 186M | 163M | 147M | 144M | 118M | 124M |
BridgeBio Pharma, Inc. Income Statement — FAQ
BridgeBio Pharma, Inc. (BBIO) income statement over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBIO's income statement history?
The chart and table above show BridgeBio Pharma, Inc.'s income statement by year and by quarter, including the growth rate.